Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Debt / NOTE 2.750% 4/0
-
Market price (% of par)
-
93.59%
-
Total 13F principal
-
$178,031,689
-
Principal change
-
-$999,000
-
Total reported market value
-
$177,212,353
-
Number of holders
-
13
-
Value change
-
+$719,815
-
Number of buys
-
4
-
Number of sells
-
2
Institutional Holders of NEVRO CORP - NOTE 2.750% 4/0 as of Q1 2023
As of 31 Mar 2023,
NEVRO CORP - NOTE 2.750% 4/0 was held by
13 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$178,031,689
in principal (par value) of the bond.
The largest 10 bondholders included
BRAIDWELL LP, Linden Advisors LP, Opti Capital Management, LP, PFM Health Sciences, LP, CAPSTONE INVESTMENT ADVISORS, LLC, FMR LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, Rock Springs Capital Management LP, and CITIGROUP INC.
This page lists
13
institutional bondholders reporting positions
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.